Skip to content
Malawi Clinical GuidelinesGuidelinesGet app

18.5

Selecting regimen and formulation for continuation

Clinical HIV Guidelines, 5th Edition, 2022. Chapter 18, Continuing ART.

Clinical description

  • Don’t change regimen without clear medical indication. Unnecessary changes spoil future

treatment options.

Do NOT change ART regimen:

  • If a patient has moderate insomnia/headache after starting a regimen with DTG. However,

substitute with an alternative drug if symptoms have not disappeared after a month.

Change dosage and formulation:

  • Review current weight for children and adjust dosing if necessary. (See Table 17 on page 70).
  • Start a new ART Patient Card – Adult ARV Formulations for children who change from paediatric to

adult ARV formulation. File together with the old card.

Change ART regimen:

  • Use Table 16 on page 68 to select the appropriate alternative regimen. Change patients with

significant side-effects immediately. Change patients with troubling side-effects that did not improve after 2 months of symptomatic treatment.

  • Adjust regimen and formulation according to current weight:

o Transition all children on regimen 9P to 15PP o Move to 15PA when they reach 20kg o Move to 15A when they reach 25kg o Move to 13A once they weigh over 30kg. This is to reduce the pill burden and benefit from optimised treatment regimens.

  • Add any new regimen to the ART Regimens history section on the card header and specify any non-

standard regimen here.

  • Multiple contraindications / side-effects may require NS regimen (see Section 14.3 on page 71)
Spotted an error? Report it by

Need this without data?

The app holds every guideline on your device, with calculators, bookmarks and notes.